Neurogenetics Patient Registry for Genetic Disorders

Neurogenetics Patient Registry

Recruiting Observational Study
Neurogenetic Disorders
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Sex
Any
Study type
Observational
Participants needed
1,000 (estimated)
Sponsor
University of Pittsburgh · Other
Who this trial is looking for

This trial is looking for patients who may have neurogenetic disorders. Participants will provide clinical information and may undergo genetic testing as part of the research.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been evaluated at the Neurogenetics clinic.
  • I suspect I have an underlying neurogenetic disorder.
  • I have known abnormal genetic testing related to my neurological symptoms.

You may not be able to join if

  • I have an acquired diagnosis that explains my symptoms.
  • My clinical symptoms or family history do not suggest a genetic reason.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
The objective of this project is to develop a Neurogenetics patient database and bio repository - which includes clinical information regarding history, physical examination, laboratory testing including genetic testing (NextGen sequencing including whole exome and whole genome sequencing, SNParray, etc.), neuroradiology studies, neurophysiology studies - all ordered as clinically deemed appropria…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients evaluated at the Neurogenetics clinic and suspected to have an underlying neurogenetic disorder will be included. * Patients with known abnormal genetic testing with a neurological phenotype will be included. Exclusion Criteria: * Patient with acquired diagnosis, wh…
Contacts

Jennifer Baker, MA

412-69-26378

jennifer.baker@chp.edu

CONTACT